Luye Pharma Group Ltd.

HKEX:2186.HK

3.02 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Operating Activities:
Net Income 700.1669.762-74.557942.1741,771.6551,473.471,116.321974.722898.132725.514383.168169.032201.128195.42166.20962.08958.98180.91290.16471.83742.576
Depreciation & Amortization 701.851671.313581.982510.899442.031317.185249.787140.92115.209110.445100.43478.50878.95170.20944.84041.18615.10911.72211.06410.307
Deferred Income Tax 00-311.915-505.883-422.494-411.508-317.46600000000000000
Stock Based Compensation 20.6425.44550.07951.25265.78531.3396.25100000000000000
Change In Working Capital 397.988319.792-418.082-300.328-289.636-486.151-113.614-308.446-410.212-375.54638.082-95.346112.96950.88-13.30905.255-4.821-39.756-38.542-19.529
Accounts Receivables -570.84-18.767-211.76144.998-166.612-120.0623.789-115.888-278.973-378.568-21.304-58.932000000000
Inventory -54.924-26.595-134.0414.875-29.013-165.25332.314-43.054-34.411-16.465-92.047-36.414-9.17-14.4913.9303.54-4.539-0.705-12.28-3.334
Accounts Payables 018.767211.76-144.998166.6120000000000000000
Other Working Capital 891.379346.387-284.041-305.203-260.623-320.898-145.928-265.392-375.801-359.081130.1290122.13965.371-17.23901.715-0.282-39.051-26.262-16.195
Other Non Cash Items 564.723-32.516354.967335.683178.664121.25222.823-215.168-208.421-141.317-83.066-94.638-68.03-62.3-34.58343.81433.084-40.199-19.2583.6316.978
Operating Cash Flow 1,595.4871,653.796182.3711,033.4491,744.8971,045.587964.102592.028394.708319.096438.618152.902325.018254.209163.157105.903138.50651.00142.87247.9940.332
Investing Activities:
Investments In Property Plant And Equipment -1,165.261-1,163.659-1,541.595-1,519.883-3,223.039-2,484.515-625.182-319.141-208.092-289.275-270.923-146.24-338.23-140.637-24.509-44.265-13.956-9.379-29.403-11.479-13.181
Acquisitions Net -1,3800-808.514-450.788-2,085.088-1,655.188-5.39-1,674.489700-7002.0650-271.924-46.1811.3010.401-167.0560000
Purchases Of Investments -1,627.642-3,485.94-3,975.664-2,859.22-3,073.609-3,958.846-4,676.375-4,554-5,919.311-1,840.465-10000-45.126000-4.03500
Sales Maturities Of Investments 2,592.7122,899.4911,919.0024,153.8453,397.353,326.0924,498.0634,610.5675,655.0825.8921.0080000.153000000
Other Investing Activites 4.04391.8970.739814.2432,292.8461,774.70965.188102.16812.641-174.939-275.51811.11-32.97-4.2381.95340.2272.669-335.056-11.154-3.5820.475
Investing Cash Flow -1,418.258-1,658.308-3,436.032138.197-2,691.54-2,997.748-743.696-1,834.895240.318-2,978.787-553.368-135.13-643.124-191.056-66.228-3.637-178.343-344.435-44.592-15.061-12.706
Financing Activities:
Debt Repayment -454.455-8,301.897-7,536.692-5,896.686-6,739.241-3,276.786-2,629.55-2,282.817-1,294.293-2,187.013-1,023.915-809.366-448.729-295.091-164.716-203.003-161.799-59-49-110.01-106.292
Common Stock Issued 922.965189.1561,044.4777,326.738,828.7841.646-281.204003,139.34000000161.799320.4220104.1110
Common Stock Repurchased 000-77.962-8.776-21.605-178.08000000-3.100-2.011590420
Dividends Paid 000-175.487-376.778-289.719-212.629-106.9760000000-14.398-19.103-16.454-14.292-0.8-17.383
Other Financing Activities 425.6348,166.8898,371.112-922.614-97.233-560.8164,034.043,209.8061,345.6031,705.4851,111.23591.517618.201359.862224.62990.718108.2614.6442.7410.3127.41
Financing Cash Flow 841.59954.1481,878.897253.9811,606.7562,404.646732.577820.01351.312,657.81287.3291.517169.47261.67159.913-126.68387.146318.612-60.55245.6013.735
Other Information:
Effect Of Forex Changes On Cash -103.595-164.148-52.369112.409-7.532-45.492-84.886-23.0455.4750.592-3.4513.241000000000
Net Change In Cash 915.233-114.512-1,427.1331,538.036652.581406.993868.097-445.899691.811-1.287-30.881112.53-148.634124.824156.842-24.41747.30925.178-62.27278.5331.361
Cash At End Of Period 3,238.9732,323.742,438.2523,865.3852,325.4461,672.8651,265.872397.775843.674331.863333.15364.031251.501400.135275.311118.469142.88695.57770.399132.67154.141